Intratympanic Injection of Edaravone for Idiopathic Sudden Sensorineural Hearing Loss with Profound Hearing Loss

The final hearing thresholds of patients treated with ITE were significantly better than those of patients treated with ITS. It has been concluded that ITE treatment may be useful in future clinical studies.

Authors

Institutions

Publication Details

Journal
The Journal of International Advanced Otology
Published
2025-05-22
DOI
https://doi.org/10.5152/iao.2025.251875
Citations
1
Primary Topic
Vestibular and auditory disorders
Type
article
Field-Weighted Citation Impact
0.84
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Intratympanic Injection of Edaravone for Idiopathic Sudden Sensorineural Hearing Loss with Profound Hearing Loss

Takaomi Kurioka, Hajime Sano, Yoshihiro Nitta, Taku Yamashita
1 citations
The Journal of International Advanced Otology
Vestibular and auditory disorders
0.84
article

Intratympanic Injection of Edaravone for Idiopathic Sudden Sensorineural Hearing Loss with Profound Hearing Loss

Takaomi Kurioka, Hajime Sano, Yoshihiro Nitta, Taku Yamashita
article en
1 citations

Abstract

The final hearing thresholds of patients treated with ITE were significantly better than those of patients treated with ITS. It has been concluded that ITE treatment may be useful in future clinical studies.

The Journal of International Advanced OtologyVol. 21(3)
Kitasato University (JP)
Openalex Percentile: Top 26%
Vestibular and auditory disorders
0.84
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.